In adaptive immunity, it has previously been shown that patients with AF have higher levels of autoantibodies, including anti-β1-adrenergic receptor (anti-β1-AR) and anti-M2-muscarinic receptor (anti-M2-R) (Yalcin et al., 2015). The gene discussed is ADRB1; the disease is atrial fibrillation.